Raloxifene administration enhances retention in an orthodontic relapse model

BACKGROUND AND OBJECTIVES: Orthodontic relapse is a physiologic process that involves remodelling of the alveolar bone and principle periodontal ligament fibres. Raloxifene is an Food and Drug Administration (FDA)-approved selective oestrogen receptor modulator that inhibits systemic bone loss. In o...

Full description

Saved in:
Bibliographic Details
Published in:Eur J Orthod
Main Authors: Azami, Niloufar, Chen, Po-Jung, Mehta, Shivam, Kalajzic, Zana, Dutra, Eliane H, Nanda, Ravindra, Yadav, Sumit
Format: Artigo
Language:Inglês
Published: Oxford University Press 2020
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7485273/
https://ncbi.nlm.nih.gov/pubmed/32065225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ejo/cjaa008
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items